Calliope Biophysics utilizes patented technology derived from aerospace engineering to enhance cancer detection through real-time diagnostic tools for surgeons. The company aims to improve tissue analysis accuracy, enabling earlier and more effective interventions for cancer patients.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for intraoperative tissue analysis can be slow and lack precision, potentially leading to incomplete tumor removal or unnecessary removal of healthy tissue. This can result in increased risk of cancer recurrence and complications for patients undergoing surgery.
Solution
Calliope Biophysics offers real-time diagnostic tools for surgeons to improve the accuracy of tissue analysis during cancer surgery. By leveraging patented technology derived from aerospace engineering, the company's platform provides enhanced visualization and characterization of tissue at the cellular level. This enables surgeons to make more informed decisions regarding tissue resection, ensuring complete removal of cancerous cells while preserving healthy tissue. The platform aims to reduce the need for repeat surgeries and improve overall patient outcomes.
Target Audience
The primary target audience includes surgeons, hospitals, and cancer centers seeking to improve the precision and efficiency of cancer surgery.
Features
- Real-time tissue analysis during surgical procedures
- Patented technology derived from aerospace engineering
- Enhanced visualization and characterization of tissue at the cellular level
- Improved accuracy in identifying cancerous tissue